Stock Scorecard
Stock Summary for Nature`s Sunshine Products Inc (NATR) - $18.70 as of 4/18/2024 10:07:48 PM EST
Total Score
22 out of 29
Currently on the following lists
Growth Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for NATR
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NATR
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NATR
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for NATR
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for NATR
Financial Details for NATR
Company Overview |
|
---|---|
Ticker | NATR |
Company Name | Nature`s Sunshine Products Inc |
Country | USA |
Description | Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company is headquartered in Lehi, Utah. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/7/2024 |
Stock Price History |
|
Last Day Price | 18.70 |
Last Day Price Updated | 4/18/2024 10:07:48 PM EST |
Last Day Volume | 53,531 |
Average Daily Volume | 64,165 |
52-Week High | 21.72 |
52-Week Low | 10.06 |
Last Price to 52 Week Low | 85.88% |
Valuation Measures |
|
Trailing PE | 24.56 |
Industry PE | 100.90 |
Sector PE | 61.34 |
5-Year Average PE | 37.78 |
Free Cash Flow Ratio | 4.27 |
Industry Free Cash Flow Ratio | 12.64 |
Sector Free Cash Flow Ratio | 30.17 |
Current Ratio Most Recent Quarter | 2.16 |
Total Cash Per Share | 4.38 |
Book Value Per Share Most Recent Quarter | 8.16 |
Price to Book Ratio | 2.32 |
Industry Price to Book Ratio | 5.66 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.80 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.19 |
Share Statistics |
|
Total Shares Outstanding | 18,819,100 |
Market Capitalization | 351,917,170 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/26/2021 |
Last Dividend Amount | 0.10 |
Current Dividend Amount | 1.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 1 |
3-Year Average Dividend Yield | 5.41% |
5-Year Average Dividend Yield | 5.41% |
1-Year Dividend Growth Rate Percentage | 900.00% |
3-Year Dividend Growth Rate Percentage | 58.11% |
5-Year Dividend Growth Rate Percentage | -14.83% |
All-Time Dividend Growth Rate Percentage | 16.41% |
Dividend Payout Ratio | 0.00% |
Income Statement |
|
Quarterly Earnings Growth YOY | 359.60% |
Annual Earnings Growth | 3,965.64% |
Reported EPS 12 Trailing Months | 0.77 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 0.95 |
Net Income Twelve Trailing Months | 15,076,000 |
Net Income Past Year | 15,076,000 |
Net Income Prior Year | -390,000 |
Quarterly Revenue Growth YOY | 6.00% |
5-Year Revenue Growth | 4.02% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 82,373,000 |
Total Cash Past Year | 82,373,000 |
Total Cash Prior Year | 60,032,000 |
Net Cash Position Most Recent Quarter | 82,157,000 |
Net Cash Position Past Year | 81,199,000 |
Long Term Debt Past Year | 1,174,000 |
Long Term Debt Prior Year | 1,174,000 |
Total Debt Most Recent Quarter | 216,000 |
Equity to Debt Ratio Past Year | 0.99 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 159,540,000 |
Total Stockholder Equity Prior Year | 147,047,000 |
Total Stockholder Equity Most Recent Quarter | 159,540,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.30 |
MACD Signal | 0.47 |
20-Day Bollinger Lower Band | 15.89 |
20-Day Bollinger Middle Band | 18.16 |
20-Day Bollinger Upper Band | 20.42 |
Beta | 0.82 |
RSI | 48.59 |
50-Day SMA | 15.99 |
200-Day SMA | 14.21 |
System |
|
Modified | 4/18/2024 6:37:26 AM EST |